149 related articles for article (PubMed ID: 9661906)
1. Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.
Bhaumik M; Harris T; Sundaram S; Johnson L; Guttenplan J; Rogler C; Stanley P
Cancer Res; 1998 Jul; 58(13):2881-7. PubMed ID: 9661906
[TBL] [Abstract][Full Text] [Related]
2. New evidence for an extra-hepatic role of N-acetylglucosaminyltransferase III in the progression of diethylnitrosamine-induced liver tumors in mice.
Yang X; Bhaumik M; Bhattacharyya R; Gong S; Rogler CE; Stanley P
Cancer Res; 2000 Jun; 60(12):3313-9. PubMed ID: 10866326
[TBL] [Abstract][Full Text] [Related]
3. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
Yang X; Tang J; Rogler CE; Stanley P
Cancer Res; 2003 Nov; 63(22):7753-9. PubMed ID: 14633700
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans.
Stanley P; Sundaram S; Tang J; Shi S
Glycobiology; 2005 Jan; 15(1):43-53. PubMed ID: 15329358
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients.
Kohler RS; Anugraham M; López MN; Xiao C; Schoetzau A; Hettich T; Schlotterbeck G; Fedier A; Jacob F; Heinzelmann-Schwarz V
Oncotarget; 2016 Aug; 7(32):51674-51686. PubMed ID: 27429195
[TBL] [Abstract][Full Text] [Related]
6. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction.
Priatel JJ; Sarkar M; Schachter H; Marth JD
Glycobiology; 1997 Feb; 7(1):45-56. PubMed ID: 9061364
[TBL] [Abstract][Full Text] [Related]
7. Biological consequences of overexpressing or eliminating N-acetylglucosaminyltransferase-TIII in the mouse.
Stanley P
Biochim Biophys Acta; 2002 Dec; 1573(3):363-8. PubMed ID: 12417419
[TBL] [Abstract][Full Text] [Related]
8. Truncated, inactive N-acetylglucosaminyltransferase III (GlcNAc-TIII) induces neurological and other traits absent in mice that lack GlcNAc-TIII.
Bhattacharyya R; Bhaumik M; Raju TS; Stanley P
J Biol Chem; 2002 Jul; 277(29):26300-9. PubMed ID: 11986323
[TBL] [Abstract][Full Text] [Related]
9. Antibodies that recognize bisected complex N-glycans on cell surface glycoproteins can be made in mice lacking N-acetylglucosaminyltransferase III.
Lee J; Park SH; Stanley P
Glycoconj J; 2002 Mar; 19(3):211-9. PubMed ID: 12815232
[TBL] [Abstract][Full Text] [Related]
10. The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.
Song Y; Aglipay JA; Bernstein JD; Goswami S; Stanley P
Cancer Res; 2010 Apr; 70(8):3361-71. PubMed ID: 20395209
[TBL] [Abstract][Full Text] [Related]
11. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
12. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: implications for a role in regulating invasivity.
Yamamoto H; Swoger J; Greene S; Saito T; Hurh J; Sweeley C; Leestma J; Mkrdichian E; Cerullo L; Nishikawa A; Ihara Y; Taniguchi N; Moskal JR
Cancer Res; 2000 Jan; 60(1):134-42. PubMed ID: 10646865
[TBL] [Abstract][Full Text] [Related]
13. Glycoproteomic analysis reveals the effects of bisecting GlcNAc in intrahepatic cholangiocarcinoma.
Dan W; Li C; Li J; Li P; Xin M; Chen Z; Dang L; Yu Z; Li J; Shen J; Hu L; Sun S
Glycoconj J; 2022 Dec; 39(6):737-745. PubMed ID: 36322335
[TBL] [Abstract][Full Text] [Related]
14. Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity.
Li W; Takahashi M; Shibukawa Y; Yokoe S; Gu J; Miyoshi E; Honke K; Ikeda Y; Taniguchi N
Glycobiology; 2007 Jun; 17(6):655-62. PubMed ID: 17324955
[TBL] [Abstract][Full Text] [Related]
15. Bisecting GlcNAc mediates the binding of annexin V to Hsp47.
Gao CX; Miyoshi E; Uozumi N; Takamiya R; Wang X; Noda K; Gu J; Honke K; Wada Y; Taniguchi N
Glycobiology; 2005 Nov; 15(11):1067-75. PubMed ID: 16000695
[TBL] [Abstract][Full Text] [Related]
16. The bisecting GlcNAc in cell growth control and tumor progression.
Miwa HE; Song Y; Alvarez R; Cummings RD; Stanley P
Glycoconj J; 2012 Dec; 29(8-9):609-18. PubMed ID: 22476631
[TBL] [Abstract][Full Text] [Related]
17. Expression of bisecting GlcNAc in pediatric brain tumors and its association with tumor cell response to vinblastine.
Rebbaa A; Chou PM; Vucic I; Mirkin BL; Tomita T; Bremer EG
Clin Cancer Res; 1999 Nov; 5(11):3661-8. PubMed ID: 10589784
[TBL] [Abstract][Full Text] [Related]
18. Cloning and chromosomal mapping of the mouse Mgat3 gene encoding N-acetylglucosaminyltransferase III.
Bhaumik M; Seldin MF; Stanley P
Gene; 1995 Oct; 164(2):295-300. PubMed ID: 7590346
[TBL] [Abstract][Full Text] [Related]
19. Efficient introduction of a bisecting GlcNAc residue in tobacco N-glycans by expression of the gene encoding human N-acetylglucosaminyltransferase III.
Rouwendal GJ; Wuhrer M; Florack DE; Koeleman CA; Deelder AM; Bakker H; Stoopen GM; van Die I; Helsper JP; Hokke CH; Bosch D
Glycobiology; 2007 Mar; 17(3):334-44. PubMed ID: 17179169
[TBL] [Abstract][Full Text] [Related]
20. Hyperexpression of N-acetylglucosaminyltransferase-III in liver tissues of transgenic mice causes fatty body and obesity through severe accumulation of Apo A-I and Apo B.
Lee J; Song EY; Chung TW; Kang SK; Kim KS; Chung TH; Yeom YI; Kim CH
Arch Biochem Biophys; 2004 Jun; 426(1):18-31. PubMed ID: 15130779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
